Table 3 The effect of bone turnover markers on the change in BMD in the total hip and lumbar spine at 6 months: adjusted for sex and age.

From: Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients

Variables

Total hip

Lumbar spine

β

p value

β

p value

ALP, IU/L

0.423

0.011

0.512

0.007

BAP, μg/L

0.472

0.004

0.591

0.001

TRACP-5b, mU/dL

0.433

0.008

0.613

0.0008

  1. β standardized regression coefficient, ALP alkaline phosphatase, BAP bone-specific alkaline phosphatase, TRACP-5b tartrate-resistant acid phosphatase-5b.
Back to article page